A Los Angeles County resident with a compromised immune system has died from monkeypox, local health officials announced Monday. It’s believed to be the first U.S. […]
The highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses across multiple tumor types in the Phase I/II LIBRETTO-001 trial, according to researchers […]
The treatment of blood cancers has dramatically improved in the last five years, thanks to a new class of cancer immunotherapies called CAR-T cell therapy. This […]